FY23 Results - Investor Presentation slide image

FY23 Results - Investor Presentation

Asset Quality (Continuing) | (Impairments) / Writebacks Net (Impairments) / Writebacks and GIL Ratio Total impairments by category (RM' mil) ECL Stage 1 & 2 / CP - Non defaulted¹ ECL Stage 3/CP - Defaulted Individual Provisions Recoveries Other Provisions² Total net impairments Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23 Q2FY23 Q3FY23 Q4FY23 QoQ Change FY22 FY23 YoY Change (122) (124) 56 561 6 19 (55) 17 (>100%) 371 (13) >100% (118) (85) (98) (557) (125) (155) (167) (141) (16%) (858) (588) (31%) (12) (21) (304) (3) (12) (20) (66) (41) (38%) (339) (139) (59%) 57 61 48 74 71 83 68 88 240 (8) (4) (40) (129) (6) (15) 71 26 (203) (173) (338) (53) (66) (88) (149) (51) 29% (63%) (182) (66%) (768)³ (354)³ 310 29% 76 (>100%) (54%) Total impairments by divisions (RM' mil) Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23 Q2FY23 Q3FY23 Q4FY23 QoQ Change FY22 FY23 YoY Change Wholesale Banking (68) (101) (258) (586) 21 47 (21) (1) (95%) (1,013) 46 (>100%) Investment Banking 2 7 0 2 0 (1) 0 (0) >100% 11 >100% Retail Banking (43) 5 (43) (77) (38) (121) (85) (58) (31%) (158) (302) 92% Business Banking (22) (52) 1 29 (19) (14) (100) 10 Group Funding & Others (72) (32) (39) 578 (30) 1 56 (1) Total net impairment (203) (173) (338) (53) (66) (88) (149) (51) (>100%) (44) (123) >100% 436 (66%) (768)³ (354) 3 >100% 26 (94%) (54%) GIL Ratio Wholesale Banking 2.08% 1.84% 1.98% Q1FY22 Q2FY22 Q3FY22 Q4FY22 Q1FY23 Q2FY23 Q3FY23 Q4FY23 1.66% QoQ Change YoY Change 1.34% 1.07% 1.12% 0.64% (0.48%) (1.02%) Investment Banking 0.02% 0.01% 0.01% Retail Banking 1.34% 1.30% 1.12% 0.00% 1.31% 0.00% N/A N/A Business Banking 1.90% 1.66% 1.44% 1.42% 1.71% 1.82% 1.87% 1.85% 1.47% (0.02%) 0.55% 1.37% 1.65% 1.57% (0.08%) 0.15% Group 1.59% 1.47% 1.37% 1.40% 1.55% 1.52% 1.62% 1.46% (0.16%) 0.06% Industry 1.62% 1.73% 1.68% 1.71% 1.81% 1.82% 1.72% 1.75% 0.03% 0.04% 123 1. Includes overlay and forward-looking provision 2. 3. Includes trade & sundry debtors and provision for contingencies Excludes AmGen's net impairment of RM1.7m (FY22) and -RM113.2m (FY23) AmBank Group FY23 Results - Investor Presentation 27
View entire presentation